Source
Author: unknown
Eli Lilly to buy genetic medicine developer Akouos for $487 million [Deals Market Headlines | Breaking Stock Market News | Reuters]
Related Posts
Humana Nears $1 Billion Acquisition of MaxHealth, Targets Florida Primary Care Expansion
Humana Inc. is in advanced talks to acquire Sarasota, Florida-based MaxHealth, a primary care network, in a deal approaching $1 billion, according to Bloomberg reports. The transaction underscores...
Eli Lilly Bets $2.4 Billion on Orna Therapeutics to Advance In Vivo Cell Therapies
Eli Lilly agreed to acquire Orna Therapeutics for up to $2.4 billion in cash, securing access to proprietary circular RNA technology for in vivo cell engineering in autoimmune diseases and oncology....
Novartis Doubles Down on Early-Stage M&A Strategy as Near-Launch Assets Become Scarce
null Novartis is reinforcing its commitment to acquiring early-stage pipeline assets and clinical-stage candidates, even as the pharmaceutical giant faces intensifying competition for late-stage drug...
Mubadala Exits Arcadia Consumer Healthcare as Bansk Group Assumes Full Control in Continuation Vehicle
Mubadala Capital has sold its minority stake in Arcadia Consumer Healthcare to funds managed by Bansk Group, marking the end of a four-year partnership that tripled the platform's revenue and...